Reported Friday, Lisata Therapeutics To Be Taken Private By Kuva Labs In A Deal Offering Stockholders $5.00 Per Share Plus A $1.00 Contingent Value Right Per Share
Benzinga Newsdesk 8 months ago
M&ANews
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent value right for a potential additional cash payment of $1.00 per shareBoard of directors unanimously approved the
- Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent value right for a potential additional cash payment of $1.00 per share
- Board of directors unanimously approved the transaction and recommends that stockholders tender their shares
- Transaction expected to close in the second quarter of 2026
